Plato Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Plato Investment Management's LLY Position: Q2 2026 in Review
Plato Investment Management reduced its Eli Lilly (LLY) stake by 0.13% in Q2 2026, selling an estimated $27.6K and leaving 20,772 shares worth $24.8M. The position accounts for 1.41% of the portfolio, ranked #12.
Plato Investment Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Plato Investment Management held 20,772 shares of Eli Lilly worth $24.8M as of Q2 2026.
- Plato Investment Management sold 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
- Eli Lilly made up 1.41% of Plato Investment Management's portfolio in Q2 2026, its #12 holding.
- Plato Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.